CLINICAL_TRIALS
trial_result
· 2008-03-04
Clinical Trial Update: An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
Summary
A completed NHLBI observational trial in immune thrombocytopenia examined how platelet counts relate to endogenous thrombopoietin levels, endogenous anti-thromb…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Purpura, Thrombocytopenic, Idiopathic, Immune Thrombocytopenic Purpura | Status: COMPLETED